Categories Earnings, Retail

What to expect from Dollar General earnings on Thursday

Following a string of solid performances by retailers, discount store chain Dollar General (DG) is scheduled to report earnings on August 30. Investors are expecting Dollar General to repeat the bullish trends of its rivals including TJX Companies (TJX), Ross Stores (ROST) and Kohl’s (KSS), all of which reported stellar Q2 results.

Analysts expect Dollar General to report earnings of $1.49 per share, up almost 36%, riding on a 9% revenue hike to $6.37 billion. A few analysts also have an optimistic view on the comp sales of 3%, which could very well drive the stock to a record high. DG shares have improved by 20% since the last earnings results on May 31, while it has increased about 14% year-to-date.

Dollar General earnings preveiw
Courtesy: Wikimedia Commons

Adding to the optimism on the stock ahead of the earnings, analysts’ firm Oppenheimer on Monday lifted the price target on the stock from $108 to $120, an upside of 12% from the current price of $107.19.

The firm stated following the target price hike, “We still remain constructive on the dollar store space even after the recent rally. Consistent with our views the past several months, DG remains our top pick.”

If Dollar General manages to beat the expectations in Q2, we can see other analysts firms also following the suit of Oppenheimer.

The stock had shown a resilient spike in August after a month-long sideways trend starting mid-June, thanks to high consumer confidence and low jobless rates. There is a high possibility of these positive trends pushing Dollar General beyond estimates at Thursday’s results.

Also see: Dollar General misses estimates in Q1, shares down over 6%

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top